1. Home
  2. Browse Decisions
  3. F.3d
  4. 857 F.3d
  5. 857 F.3d 34 (2017)
 

IN RE BIOGEN INC. SECURITIES LITIGATION

No. 16-1976.

857 F.3d 34 (2017)

IN RE: BIOGEN INC. SECURITIES LITIGATION. GBR Group, Ltd., Plaintiff, Appellant, Nicole Tehrani, Plaintiff, v. Biogen Inc.; George A. Scangos; Paul J. Clancy; Stuart A. Kingsley, Defendants, Appellees.

United States Court of Appeals, First Circuit.

May 12, 2017.

Attorney(s) appearing for the Case

Michael P. Canty , with whom Jonathan Gardner , Guillaume Buell , Labaton Sucharow LLP, New York, NY, Andrea M. Landry , Thornton Law Firm LLP, Boston, MA, Peretz Bronstein , New York, NY, Yitzchak E. Soloveichik , and Bronstein Gewirtz & Grossman LLC were on brief, for appellants.

James R. Carroll , with whom Michael S. Hines , Sara J. van Vliet , and Skadden, Arps, Slate, Meagher & Flom LLP, Boston, MA, were on brief, for appellees.

Before Lynch, Lipez, and Kayatta, Circuit Judges.

This securities case involves allegations that corporate officials misled the public about the effect of one patient's death on sales of Tecfidera, a drug for multiple sclerosis ("MS") and the company's leading source of revenue.

GBR Group, Ltd. ("GBR") is the lead plaintiff in a putative class action against Biogen...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases